Gibbs Thomas Edward 4
4 · OptiNose, Inc. · Filed Oct 16, 2017
Insider Transaction Report
Form 4
OptiNose, Inc.OPTN
Gibbs Thomas Edward
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2017-10-12+72,197→ 72,197 totalExercise: $16.00Exp: 2027-10-11→ Common Stock (72,197 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable over a four-year period commencing on October 12, 2017. Twenty-five percent (25%) of the option vests and becomes exercisable on October 12, 2018, and the balance vests in equal monthly installments (rounded down to the nearest whole share) over the remaining three years of the four-year period, subject to continued service with the Issuer.